REGENERON PHARMACEUTICALS, INC.: 13F holdings
CIK 8725892026Q2
| Positions | 3 |
|---|
| Reported value | $177.2m |
|---|
| Filed | 2026-08-07 |
|---|
Change since last quarter
| Positions | 3 (+1 vs prior quarter) |
|---|
| Reported value | $177.2m (+270.1%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| PBLS Parabilis Medicines, Inc. | 4,166,666 | $114.0m | 64.4% |
| NTLA Intellia Therapeutics, Inc. | 3,702,995 | $62.7m | 35.4% |
| Adicet Bio, Inc. | 60,511 | $522,819 | 0.3% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="872589")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples